Q BioMed plans to accelerate up to four more assets

Established in June 2015, Q BioMed, the NYC-based biomedical acceleration development company, is looking to add three to four more assets to its portfolio. Company founder and CEO, Denis Corin, outlines to Mike Ward, Informa Pharma Intelligence’s insights global director of content, the progress Q BioMed has made with its first two assets and details his ambition to expand further in the coming two to three years.

Interviewer: Mike Ward – Global Director of Content, Informa Pharma Insights
Interviewee: Denis Corin – CEO and Chairman, Q Biomed Inc.